ALN-5288
/ Alnylam
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 16, 2025
A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease
(clinicaltrials.gov)
- P1 | N=50 | Not yet recruiting | Sponsor: Alnylam Pharmaceuticals
New P1 trial • Alzheimer's Disease • CNS Disorders
1 to 1
Of
1
Go to page
1